Seagen Inc.:輝瑞以430億美元收購Seagen 加強癌症藥物開發
輝瑞以430億美元收購Seagen 加強癌症藥物開發
2023 年截至目前最大型收購案登場!輝瑞(Pfizer) 斥資430 ...
https://geneonline.news
Seagen 為來自美國華盛頓州的生技公司,創立於1998 年,專注於抗體藥物複合體(Antibody-Drug Conjugates, ADC)的癌症藥物開發,並自稱為ADC 技術的先驅 ...
Our History – Seagen
https://www.seagen.com
Seattle Genetics, Inc. changes its name to Seagen Inc. to reflect the transformation of the company from its Seattle roots into a global operation. 2021.
Pfizer + Seagen
https://www.pfizer.com
Seagen, a world-leader in antibody-drug conjugates (ADCs), we will be at the forefront of cancer care. Together, we will bring new hope to patients everywhere.
Pfizer Completes Acquisition of Seagen
https://www.pfizer.com
Seagen is a world-leader in ADC technology, a transformative modality that is emerging as a powerful tool across a broad range of cancers ...
Seagen
https://en.wikipedia.org
Seagen Inc. (formerly Seattle Genetics, Inc.) is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal ...
Seagen
https://www.seagen.com
As a pioneer in antibody-drug conjugates (ADCs), Seagen has led the way in novel cancer therapeutics for more than 20 years ...
Seagen Inc.
https://www.moneydj.com
成立日期:1997年 上市日期:2001年 經營項目/產品: 該公司是美國的生物科技公司,專門研發,並販售可用於癌症治療的各式藥品。
SGEN - Seagen Inc (西雅圖遺傳)
https://invest.cnyes.com
西雅圖遺傳是一家生物技術公司,專注於癌症治療療法的開發和商業化。 Adcetris 是Seagen 經FDA 批准上市的主要產品,在美國、歐洲和幾個國家用於治療霍奇金淋巴瘤、某 ...